# DEDD2

## Overview
DEDD2, or death effector domain containing 2, is a gene that encodes a protein involved in the regulation of apoptosis, a form of programmed cell death crucial for maintaining cellular homeostasis. The protein encoded by DEDD2 is characterized by the presence of a death effector domain (DED), which facilitates its interactions with other proteins involved in apoptotic signaling pathways. As a nucleolar protein, DEDD2 plays a significant role in the formation of death-inducing signaling complexes (DISC) and interacts with various death receptors and adaptor proteins, such as c-FLIPs, to modulate apoptotic processes (Riley2015DED; Lo2014Tandem). Beyond its role in apoptosis, DEDD2 is also implicated in transcriptional regulation, interacting with transcription factors like TFIIIC, which suggests a broader functional scope in cellular processes (Zhan2002Death). The dysregulation of DEDD2 has been associated with several diseases, including cancer, where it influences tumor progression and response to treatment (Matsushita2018Hot; Muthu2015Identification).

## Structure
DEDD2 is a protein involved in apoptosis regulation and contains a single death effector domain (DED) located at the N-terminus (Lo2014Tandem). The DED is a protein-protein interaction domain that typically forms a six-helical bundle structure, which is a characteristic feature of the death domain (DD) superfamily (Riley2015DED; Lo2014Tandem). This structural motif is crucial for the protein's role in apoptosis signaling pathways, facilitating interactions with other DED-containing proteins such as c-FLIPs, which can induce moderate apoptosis (Lo2014Tandem).

DEDD2 is composed of 326 amino acids and is capable of translocating into the nucleus, where it may regulate the transport of other DED-containing proteins to promote pro-apoptotic activity (Lo2014Tandem). The protein's interactions and functions are likely influenced by its structural features, although specific details on its primary, tertiary, or quaternary structures are not provided in the available literature. Post-translational modifications, such as phosphorylation, may also play a role in regulating DEDD2's function, although specific modifications have not been detailed in the context provided.

## Function
DEDD2 is a nucleolar protein involved in the regulation of apoptosis, primarily through its interactions with other proteins containing death effector domains (DEDs). It contains a single DED located at the N-terminus, which facilitates its translocation into the nucleus and its interaction with c-FLIP, a protein with an inactive caspase domain. This interaction is crucial for negatively regulating nuclear events during apoptosis, thereby influencing cell death and survival (Lo2014Tandem; Kaur2021Bacterial).

In healthy human cells, DEDD2 is implicated in the regulation of nuclear transport and apoptotic activity. It can bind to c-FLIPs and induce moderate apoptosis, suggesting a role in maintaining cellular homeostasis by modulating apoptotic pathways (Lo2014Tandem). The protein's involvement in apoptosis is further supported by its participation in the formation of the death-induced signaling complex (DISC), which is essential for the extrinsic apoptotic pathway. This pathway involves interactions with death receptors and adaptor proteins like FADD, leading to the activation of initiator caspases such as caspase-8 and caspase-10 (Lo2014Tandem).

DEDD2's role in apoptosis and immune response is also linked to its domain architecture, which shows diversity across species, suggesting evolutionary adaptations that enhance its function in countering invasive elements (Kaur2021Bacterial).

## Clinical Significance
DEDD2 (death effector domain containing 2) plays a significant role in apoptosis and its dysregulation has been implicated in various diseases. In cancer, alterations in DEDD2 expression have been associated with the progression and treatment response of several types. For instance, in non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC), compounds like CFM-4 and CFM-4.6 elevate DEDD2 expression, promoting apoptosis and inhibiting cancer cell growth (Muthu2015Identification). Similarly, in pancreatic cancer cells, the upregulation of DEDD2 following treatment with Agaricus blazei Murrill extract suggests a role in enhancing apoptosis (Matsushita2018Hot).

In Leydig cell tumors, DEDD2 is downregulated, which may contribute to the disruption of apoptotic pathways and tumor development (Kotula‐Balak2021Transcriptome). In Hodgkin lymphoma, DEDD2 interacts with caspase-8 and caspase-3, promoting apoptosis, especially when combined with pro-apoptotic agents like TRAIL (Zhao2008Bortezomib). Genetic deletions involving DEDD2 have been observed in cases with developmental anomalies, although the specific clinical significance of these deletions remains unclear (Singh2021Deletion). These findings highlight the importance of DEDD2 in apoptosis and its potential impact on cancer and other diseases.

## Interactions
DEDD2 interacts with several proteins and nucleic acids, playing a role in apoptotic and transcriptional regulation processes. It contains a death effector domain (DED) that facilitates interactions with other DED-containing proteins, such as c-FLIPs, which can induce moderate apoptosis (Lo2014Tandem). DEDD2 is involved in the formation of death-inducing signaling complexes (DISC) through interactions with death receptors like TRAIL-R1, TRAIL-R2, and CD95, and it participates in recruiting other DED-containing proteins, such as procaspase-8 and procaspase-10, to facilitate apoptosis (Riley2015DED).

DEDD2 also interacts with the transcription factor TFIIIC, specifically the hTFIIIC102 subunit, suggesting a role in transcription regulation. This interaction can lead to the sequestration of hTFIIIC102 in the nucleus, potentially inhibiting NF-kB-regulated gene expression (Zhan2002Death). The protein's interaction with c-FLIP is involved in the negative regulation of nuclear events during apoptosis (Kaur2021Bacterial). These interactions highlight DEDD2's dual role in apoptosis and transcriptional regulation, indicating its importance in cellular processes beyond apoptosis alone.


## References


[1. (Riley2015DED) J S Riley, A Malik, C Holohan, and D B Longley. Ded or alive: assembly and regulation of the death effector domain complexes. Cell Death &amp; Disease, 6(8):e1866–e1866, August 2015. URL: http://dx.doi.org/10.1038/cddis.2015.213, doi:10.1038/cddis.2015.213. This article has 63 citations.](https://doi.org/10.1038/cddis.2015.213)

[2. (Zhan2002Death) Y Zhan, R Hegde, S M Srinivasula, T Fernandes-Alnemri, and E S Alnemri. Death effector domain-containing proteins dedd and flame-3 form nuclear complexes with the tfiiic102 subunit of human transcription factor iiic. Cell Death &amp; Differentiation, 9(4):439–447, March 2002. URL: http://dx.doi.org/10.1038/sj.cdd.4401038, doi:10.1038/sj.cdd.4401038. This article has 20 citations.](https://doi.org/10.1038/sj.cdd.4401038)

[3. (Kaur2021Bacterial) Gurmeet Kaur, Lakshminarayan M Iyer, A Maxwell Burroughs, and L Aravind. Bacterial death and tradd-n domains help define novel apoptosis and immunity mechanisms shared by prokaryotes and metazoans. eLife, June 2021. URL: http://dx.doi.org/10.7554/elife.70394, doi:10.7554/elife.70394. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.70394)

[4. (Matsushita2018Hot) Yoshihisa Matsushita, Yoshiyuki Furutani, Rumiko Matsuoka, and Toru Furukawa. Hot water extract of agaricus blazei murrill specifically inhibits growth and induces apoptosis in human pancreatic cancer cells. BMC Complementary and Alternative Medicine, December 2018. URL: http://dx.doi.org/10.1186/s12906-018-2385-4, doi:10.1186/s12906-018-2385-4. This article has 17 citations.](https://doi.org/10.1186/s12906-018-2385-4)

[5. (Singh2021Deletion) Ram Singh, Ana S.A. Cohen, Cathryn Poulton, Tina Duelund Hjortshøj, Moe Akahira-Azuma, Geetu Mendiratta, Wahab A. Khan, Dimitar N. Azmanov, Karen J. Woodward, Maria Kirchhoff, Lisong Shi, Lisa Edelmann, Gareth Baynam, Stuart A. Scott, and Ethylin Wang Jabs. Deletion of erf and cic causes abnormal skull morphology and global developmental delay. Molecular Case Studies, 7(3):a005991, June 2021. URL: http://dx.doi.org/10.1101/mcs.a005991, doi:10.1101/mcs.a005991. This article has 3 citations.](https://doi.org/10.1101/mcs.a005991)

[6. (Kotula‐Balak2021Transcriptome) Malgorzata Kotula‐Balak, Michal Duliban, Artur Gurgul, Izabela Krakowska, Pawel Grzmil, Barbara Bilinska, and Jan Karol Wolski. Transcriptome analysis of human leydig cell tumours reveals potential mechanisms underlying its development. Andrologia, September 2021. URL: http://dx.doi.org/10.1111/and.14222, doi:10.1111/and.14222. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/and.14222)

[7. (Zhao2008Bortezomib) Xiaoxian Zhao, Wansong Qiu, Jiachun Kung, Xinyu Zhao, Xuejun Peng, Mani Yegappan, Belinda Yen-Lieberman, and Eric D. Hsi. Bortezomib induces caspase-dependent apoptosis in hodgkin lymphoma cell lines and is associated with reduced c-flip expression: a gene expression profiling study with implications for potential combination therapies. Leukemia Research, 32(2):275–285, February 2008. URL: http://dx.doi.org/10.1016/j.leukres.2007.05.024, doi:10.1016/j.leukres.2007.05.024. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.leukres.2007.05.024)

[8. (Muthu2015Identification) Magesh Muthu, Jaganmohan Somagoni, Vino T. Cheriyan, Sara Munie, Edi Levi, Abdelkader E. Ashour, Alaa Eldeen B. Yassin, Ahmed M. Alafeefy, Paula Sochacki, Lisa A. Polin, Kaladhar B. Reddy, Scott D. Larsen, Mandip Singh, and Arun K. Rishi. Identification and testing of novel carp-1 functional mimetic compounds as inhibitors of non-small cell lung and triple negative breast cancers. Journal of Biomedical Nanotechnology, 11(9):1608–1627, September 2015. URL: http://dx.doi.org/10.1166/jbn.2015.2099, doi:10.1166/jbn.2015.2099. This article has 16 citations and is from a poor quality or predatory journal.](https://doi.org/10.1166/jbn.2015.2099)

[9. (Lo2014Tandem) Yu-Chih Lo, Su-Chang Lin, Chao-Yu Yang, and Jung-Yu Tung. Tandem deds and cards suggest novel mechanisms of signaling complex assembly. Apoptosis, 20(2):124–135, November 2014. URL: http://dx.doi.org/10.1007/s10495-014-1054-4, doi:10.1007/s10495-014-1054-4. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10495-014-1054-4)